Fenoldopam monohydrobromide

• 产品号: F6800
• CAS号: 67287-54-1
• 分子式: C16H17BrClNO3
• 分子量: 386.66808
• 纯 度: ≥98%
• 保 存: protect from light

产品别名

• 标题: Fenoldopam monohydrobromide
• IUPAC标准名: 6-chloro-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol hydrobromide
• IUPAC传统名: fenoldopam hydrobromide
• 别名: SKF-82526; 6-Chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol monohydrobromide

产品登记号

• EC号: 266-634-7
• CAS号: 67287-54-1
• PubChem SID: 24278441

产品性质

• 纯度: ≥98%
• 相关基因信息: human ... ADRA1A(148), ADRA1B(147), ADRA1D(146), DRD1(1812)
• 外观: off-white
• 溶解度: DMSO: >12 mg/mL
• 溶解度: H2O: soluble4.75 mg/mL
• GHS警示词: Danger
• GHS危险声明: H302-H317-H319-H334
• 欧盟危险性物质标志: 有害性(Harmful) (Xn)
• 个人保护装置: dust mask type N95 (US), Eyeshields, Faceshields, Gloves
• GHS警示性声明: P261-P280-P305 + P351 + P338-P342 + P311
• 危险公开号: 22-36-42/43
• 安全公开号: 22-26-36/37/39
• 保存条件: protect from light
• 保存条件: under inert gas
• 保存温度: 2-8°C
• 德国WGK号: 3

产品详细信息

详细说明 (English)

Biochem/physiol Actions
Fenoldopam is a selective dopamine agonist that is being considered for the parenteral treatment of systemic hypertension. In both an oral and parenteral form, fenoldopam causes peripheral vasodilation by stimulating dopamine-1 adrenergic receptors. Intravenous fenoldopam may provide advantages over sodium nitroprusside because it can induce both a diuresis and natriuresis, is not light sensitive, and is not associated with cyanide toxicity. There is no evidence for rebound hypertension after discontinuation of fenoldopam infusion.